| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1340850
[patent_doc_number] => 06589940
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-08
[patent_title] => 'Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/296477
[patent_app_country] => US
[patent_app_date] => 1999-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18572
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589940.pdf
[firstpage_image] =>[orig_patent_app_number] => 09296477
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/296477 | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof | Apr 21, 1999 | Issued |
Array
(
[id] => 6870583
[patent_doc_number] => 20030083273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'ANTISENSE OLIGOMERS'
[patent_app_type] => new
[patent_app_number] => 09/295189
[patent_app_country] => US
[patent_app_date] => 1999-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12938
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083273.pdf
[firstpage_image] =>[orig_patent_app_number] => 09295189
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/295189 | ANTISENSE OLIGOMERS | Apr 19, 1999 | Abandoned |
Array
(
[id] => 1585174
[patent_doc_number] => 06358741
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Connective tissue growth factor (CTGF) and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/292036
[patent_app_country] => US
[patent_app_date] => 1999-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 3
[patent_no_of_words] => 16539
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358741.pdf
[firstpage_image] =>[orig_patent_app_number] => 09292036
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/292036 | Connective tissue growth factor (CTGF) and methods of use | Apr 13, 1999 | Issued |
Array
(
[id] => 9233028
[patent_doc_number] => 08598332
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-12-03
[patent_title] => 'Methods and means for obtaining modified phenotypes'
[patent_app_type] => utility
[patent_app_number] => 09/287632
[patent_app_country] => US
[patent_app_date] => 1999-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 18721
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09287632
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/287632 | Methods and means for obtaining modified phenotypes | Apr 6, 1999 | Issued |
Array
(
[id] => 4355597
[patent_doc_number] => 06218371
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines'
[patent_app_type] => 1
[patent_app_number] => 9/286098
[patent_app_country] => US
[patent_app_date] => 1999-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 21678
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218371.pdf
[firstpage_image] =>[orig_patent_app_number] => 286098
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/286098 | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines | Apr 1, 1999 | Issued |
Array
(
[id] => 4269351
[patent_doc_number] => 06322976
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Compositions and methods of disease diagnosis and therapy'
[patent_app_type] => 1
[patent_app_number] => 9/270542
[patent_app_country] => US
[patent_app_date] => 1999-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 32
[patent_no_of_words] => 59943
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/322/06322976.pdf
[firstpage_image] =>[orig_patent_app_number] => 270542
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/270542 | Compositions and methods of disease diagnosis and therapy | Mar 16, 1999 | Issued |
| 09/194230 | COMPOSITIONS AND METHODS FOR ANTISENSE INHIBITION OF PROTEIN TRANSLATION | Feb 23, 1999 | Abandoned |
| 09/256694 | SEQUENCES FOR IMPROVING THE EFFICIENCY OF SECRETION OF NON-SECRETED PROTEINS FROM MAMMALIAN AND INSECT CELLS | Feb 23, 1999 | Abandoned |
| 09/242742 | INDUCIBLE METHOD FOR PRODUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUSES UTILIZING T7 POLYMERASE | Feb 21, 1999 | Abandoned |
| 09/243102 | SYSTEMIC DELIVERY OF SERUM STABLE PLASMID LIPID PARTICLES FOR CANCER THERAPY | Feb 1, 1999 | Abandoned |
| 09/241653 | METHODS FOR REGULATING HEMATOPOIESIS USING CPG-OLIGONUCLEOTIDES | Feb 1, 1999 | Abandoned |
Array
(
[id] => 1570466
[patent_doc_number] => 06498148
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host\'s antigen immune responsiveness to a Th1 phenotype'
[patent_app_type] => B1
[patent_app_number] => 09/235742
[patent_app_country] => US
[patent_app_date] => 1999-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 11342
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498148.pdf
[firstpage_image] =>[orig_patent_app_number] => 09235742
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/235742 | Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype | Jan 20, 1999 | Issued |
| 09/232170 | METHOD OF DETERMINING THE FUUNCTION OF NUCLEOTIDE SEQUENCES AND THE PROTEINS THEY ENCODE BY TRANSFECTING THE SAME INTO A HOST | Jan 14, 1999 | Abandoned |
| 09/221222 | METHODS OF GENE MAPPING AND DISEASE DIAGNOSIS, AND GENETIC MUTATIONS UNDERLYING THE INSULIN-RESISTANT PHENOTYPE | Dec 22, 1998 | Abandoned |
Array
(
[id] => 4181322
[patent_doc_number] => 06150162
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Antisense modulation of CD44 expression'
[patent_app_type] => 1
[patent_app_number] => 9/213719
[patent_app_country] => US
[patent_app_date] => 1998-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27929
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150162.pdf
[firstpage_image] =>[orig_patent_app_number] => 213719
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/213719 | Antisense modulation of CD44 expression | Dec 16, 1998 | Issued |
Array
(
[id] => 4358626
[patent_doc_number] => 06174872
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Method for treating allergic lung disease'
[patent_app_type] => 1
[patent_app_number] => 9/212064
[patent_app_country] => US
[patent_app_date] => 1998-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 11253
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/174/06174872.pdf
[firstpage_image] =>[orig_patent_app_number] => 212064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/212064 | Method for treating allergic lung disease | Dec 14, 1998 | Issued |
Array
(
[id] => 6838454
[patent_doc_number] => 20030035794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'GENE-THERAPEUTIC NUCLEIC ACID CONSTRUCT, PRODUCTION OF SAME AND USE OF SAME IN THE TREATMENT OF HEART DISORDERS'
[patent_app_type] => new
[patent_app_number] => 09/068751
[patent_app_country] => US
[patent_app_date] => 1998-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8488
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20030035794.pdf
[firstpage_image] =>[orig_patent_app_number] => 09068751
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/068751 | GENE-THERAPEUTIC NUCLEIC ACID CONSTRUCT, PRODUCTION OF SAME AND USE OF SAME IN THE TREATMENT OF HEART DISORDERS | Nov 1, 1998 | Abandoned |
Array
(
[id] => 1030996
[patent_doc_number] => 06878547
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-12
[patent_title] => 'Antisense oligonucleotides against tenascin for treating vitiligo'
[patent_app_type] => utility
[patent_app_number] => 09/554267
[patent_app_country] => US
[patent_app_date] => 1998-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6268
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878547.pdf
[firstpage_image] =>[orig_patent_app_number] => 09554267
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/554267 | Antisense oligonucleotides against tenascin for treating vitiligo | Oct 28, 1998 | Issued |
| 09/167750 | METHODS OF GENE MAPPING AND DISEASE DIAGNOSIS, AND GENETIC MUTATIONS UNDERLYING THE INSULIN-RESISTANT PHENOTYPE | Oct 6, 1998 | Abandoned |
Array
(
[id] => 732192
[patent_doc_number] => 07037674
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-02
[patent_title] => 'Cytochrome P450 reductases from poppy plants'
[patent_app_type] => utility
[patent_app_number] => 09/486757
[patent_app_country] => US
[patent_app_date] => 1998-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 9607
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037674.pdf
[firstpage_image] =>[orig_patent_app_number] => 09486757
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486757 | Cytochrome P450 reductases from poppy plants | Aug 27, 1998 | Issued |
